NovaBridge Biosciences ADR

NBPNASDAQ · USD
1.40USD+0.04 (+2.95%)
152

NovaBridge Biosciences ADR (NBP) Historical Volatility

NBP 30-day historical volatility is 42%. This ranks in the 1th percentile of readings over the past year.

Read more

Tracking NBP historical volatility helps you see how much NovaBridge Biosciences ADR's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, NovaBridge Biosciences ADR's HV tells you what really happened. Use our scanner to monitor NBP 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The NBP 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing NovaBridge Biosciences ADR's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor.

The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts NovaBridge Biosciences ADR's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where NBP HV is running hot, cold, or in line. Make the NBP 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of October 5, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of October 5, 2026

See how volatility has moved over time

Track NBP historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial